Single Dose DNA Vaccine for Tuberculosis
Author Information
Author(s): Rosada Rogério S, Torre Lucimara Gaziola de la, Frantz Fabiani G, Trombone Ana PF, Zárate-Bladés Carlos R, Fonseca Denise M, Souza Patrícia RM, Brandão Izaíra T, Masson Ana P, Soares Édson G, Ramos Simone G, Faccioli Lúcia H, Silva Célio L, Santana Maria HA, Coelho-Castelo Arlete AM
Primary Institution: Núcleo de Pesquisas em Tuberculose, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil
Hypothesis
Can a single intranasal dose of a DNA-hsp65 vaccine complexed with cationic liposomes effectively protect against tuberculosis in mice?
Conclusion
A single intranasal dose of the COMP-hsp65 vaccine significantly reduced bacterial load in the lungs of mice, comparable to multiple doses of naked DNA.
Supporting Evidence
- A single intranasal immunization with COMP-hsp65 led to a significant reduction of bacilli in the lungs.
- This vaccine formulation allowed a 16-fold reduction in the amount of DNA administered.
- Immunization with COMP-hsp65 resulted in a Th1 immune response pattern.
- Histological examination showed minimal lung damage in vaccinated mice compared to controls.
Takeaway
Researchers created a new vaccine for tuberculosis that only needs to be given once through the nose, and it works really well at protecting mice from the disease.
Methodology
Mice were immunized with a single intranasal dose of COMP-hsp65 and compared to other vaccination methods for effectiveness against M. tuberculosis.
Limitations
The study was conducted only in mice, and further research is needed to confirm effectiveness in humans.
Participant Demographics
Female 6-week-old BALB/c mice were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website